Patents Assigned to Microbiotica Limited
  • Patent number: 11439671
    Abstract: The invention relates to bacterial compositions useful in the treatment of cancer. In particular, the compositions can be used as a co-therapy with an immune checkpoint therapy. The invention also relates to methods for identifying a subject that will respond to therapy with an immune checkpoint inhibitor comprising determining the abundance of bacteria in a biological sample from said subject.
    Type: Grant
    Filed: May 19, 2021
    Date of Patent: September 13, 2022
    Assignee: Microbiotica Limited
    Inventors: Matthew Robinson, Trevor Lawley, Michael Romanos, Kevin Vervier, Simon Harris, Ghaith Bakdash, Amy Popple, Dominika Klisko
  • Patent number: 11376285
    Abstract: The invention relates to bacterial compositions useful in the treatment of cancer. In particular, the compositions can be used as a co-therapy with an immune checkpoint therapy. The invention also relates to methods for identifying a subject that will respond to therapy with an immune checkpoint inhibitor comprising determining the abundance of bacteria in a biological sample from said subject.
    Type: Grant
    Filed: May 19, 2021
    Date of Patent: July 5, 2022
    Assignee: Microbiotica Limited
    Inventors: Matthew Robinson, Trevor Lawley, Michael Romanos, Kevin Vervier, Simon Harris